Unique Pathology Lab Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.86 M
as on 16-11-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
as on 16-11-2024
- Revenue 74.16%
(FY 2023)
- Profit 87.60%
(FY 2023)
- Ebitda 75.81%
(FY 2023)
- Net Worth 166.20%
(FY 2023)
- Total Assets 89.03%
(FY 2023)
About Unique Pathology Lab
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.86 M.
The company currently has active open charges totaling ₹3.50 M.
Neeraj Grover, Virender Bhardwaj, and Bindu Devi serve as directors at the Company.
- CIN/LLPIN
U85100DL2010PTC200141
- Company No.
200141
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Unique Pathology Lab?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Grover  | Director | 15-Mar-2010 | Current |
| Virender Bhardwaj | Director | 15-Jan-2021 | Current |
| Bindu Devi | Director | 15-Jan-2021 | Current |
Financial Performance of Unique Pathology Lab.
Unique Pathology Lab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74.16% increase. The company also saw a substantial improvement in profitability, with a 87.6% increase in profit. The company's net worth Soared by an impressive increase of 166.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unique Pathology Lab?
In 2022, Unique Pathology Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Diagnostic Bazar E-Solution Private LimitedActive 4 years 7 monthsVirender Bhardwaj and Bindu Devi are mutual person
- Surya Imaging And Pathology Centre Private LimitedActive 20 years 2 months
Bindu Devi is a mutual person
- Shubhaarambh Educational Services Private LimitedActive 1 year 3 months
Bindu Devi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 07 Dec 2010 | ₹2.45 M | Open |
Ge Capital Services India Creation Date: 22 Sep 2010 | ₹1.05 M | Open |
How Many Employees Work at Unique Pathology Lab?
Unlock and access historical data on people associated with Unique Pathology Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unique Pathology Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unique Pathology Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
